PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23967234-0	2013	Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.	Bleomycin	53-62	C-C motif chemokine ligand 2	Homo sapiens	94-98	
10229865-13	1999	The concentrations of IL-8, G-CSF, monocyte chemoattractant protein-1, GM-CSF, and TGF-beta in the supernatant fluids significantly increased in response to bleomycin.	Bleomycin	157-166	C-C motif chemokine ligand 2	Homo sapiens	35-69	
18395486-7	2008	Furthermore, in vivo, neutralization of both JE and MCP5, the two functional orthologs of CCL2, during bleomycin-induced pulmonary fibrosis significantly reduced collagen deposition as well as JE and CCR2 expression.	Bleomycin	103-112	C-C motif chemokine ligand 2	Homo sapiens	90-94	
8891198-8	1996	These experiments strongly support the hypothesis that MIP-1 alpha and MCP-1 contribute to the recruitment of leukocytes during the pulmonary inflammatory response to bleomycin challenge.	Bleomycin	167-176	C-C motif chemokine ligand 2	Homo sapiens	71-76	
7539030-9	1995	Both MCP-1 and MIP-1 alpha are expressed in a time-dependent manner after bleomycin challenge, and passive immunization of these animals with either anti-MIP-1 alpha or anti-MCP-1 antibodies attenuated leukocyte accumulation.	Bleomycin	74-83	C-C motif chemokine ligand 2	Homo sapiens	5-10	
7539030-13	1995	Our work has clearly established that the C-C chemokines MCP-1 and MIP-1 alpha are expressed and contribute to the initiation and maintenance of the bleomycin-induced pulmonary lesion.	Bleomycin	149-158	C-C motif chemokine ligand 2	Homo sapiens	57-62	
27797602-7	2016	RESULTS: Bleomycin increased intercellular adhesion molecule 1 (ICAM-1; CD54), vascular cell adhesion molecule (VCAM-1; CD106), and E-selectin (CD62E) expression, and increased monocyte chemoattractant protein (MCP-1) and interleukin (IL-8) release by endothelial cells.	Bleomycin	9-18	C-C motif chemokine ligand 2	Homo sapiens	211-216	
26209236-8	2015	These changes were accompanied by an attenuation of BLM-induced elevations in pulmonary levels of profibrotic cytokines interleukin-6, monocyte chemoattractant protein-1, and transforming growth factor-beta (TGF-beta).	Bleomycin	52-55	C-C motif chemokine ligand 2	Homo sapiens	135-169	
23967234-8	2013	CCL2 expression increased in bleomycin-injured bronchoalveolar lavage (BAL), but significantly decreased following AFSC treatment at either day 0 or at day 14.	Bleomycin	29-38	C-C motif chemokine ligand 2	Homo sapiens	0-4	
22177985-1	2012	The truncated [1+9-76] CCL2 analogue, also known as 7ND, has been described in numerous reports as an anti-inflammatory and anti-fibrotic agent in a wide spectrum of animal models, e.g. models of cardiovascular disease, graft versus host disease and bleomycin-induced pulmonary fibrosis.	Bleomycin	250-259	C-C motif chemokine ligand 2	Homo sapiens	23-27	
21741938-0	2011	Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage.	Bleomycin	102-111	C-C motif chemokine ligand 2	Homo sapiens	79-83